S100A1 decreases calcium spark frequency and alters their spatial characteristics in permeabilized adult ventricular cardiomyocytes

Overview of attention for article published in Cell Calcium, August 2006

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (71st percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

patent: 4 patents

Citations

dimensions_citation: 58 Dimensions

Readers on

mendeley: 34 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

S100 based treatment of cardiac power failure

Grant US-10792329-B2

United States of America

Muscle function enhancing peptide

Application US-9428564-B2

United States of America

S100 BASED TREATMENT OF CARDIAC POWER FAILURE

Application WO-2015049277-A1

World Intellectual Property Organisation (WIPO)

MUSCLE FUNCTION ENHANCING PEPTIDE

Application WO-2010118878-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.